FI851686L - Redskap foer anvaendning vid behandling av osteoporosis. - Google Patents

Redskap foer anvaendning vid behandling av osteoporosis.

Info

Publication number
FI851686L
FI851686L FI851686A FI851686A FI851686L FI 851686 L FI851686 L FI 851686L FI 851686 A FI851686 A FI 851686A FI 851686 A FI851686 A FI 851686A FI 851686 L FI851686 L FI 851686L
Authority
FI
Finland
Prior art keywords
osteoporosis
regimen
daily doses
foer anvaendning
redskap
Prior art date
Application number
FI851686A
Other languages
English (en)
Other versions
FI851686A0 (fi
Inventor
Vernon Albert Uchtman
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of FI851686A0 publication Critical patent/FI851686A0/fi
Publication of FI851686L publication Critical patent/FI851686L/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/16—Fluorine compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Rheumatology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Respiratory Apparatuses And Protective Means (AREA)
  • Surgical Instruments (AREA)
  • Debugging And Monitoring (AREA)
  • Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
  • Processing And Handling Of Plastics And Other Materials For Molding In General (AREA)
  • Processing Of Solid Wastes (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI851686A 1984-04-30 1985-04-29 Redskap foer anvaendning vid behandling av osteoporosis. FI851686L (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60554084A 1984-04-30 1984-04-30
US68456084A 1984-12-21 1984-12-21

Publications (2)

Publication Number Publication Date
FI851686A0 FI851686A0 (fi) 1985-04-29
FI851686L true FI851686L (fi) 1985-10-31

Family

ID=27084976

Family Applications (1)

Application Number Title Priority Date Filing Date
FI851686A FI851686L (fi) 1984-04-30 1985-04-29 Redskap foer anvaendning vid behandling av osteoporosis.

Country Status (12)

Country Link
EP (2) EP0162510B1 (fi)
JP (1) JPH0655675B2 (fi)
AT (2) ATE66608T1 (fi)
AU (1) AU584611B2 (fi)
CA (1) CA1277233C (fi)
DE (2) DE3587956T2 (fi)
DK (1) DK173735B1 (fi)
FI (1) FI851686L (fi)
HK (1) HK46694A (fi)
IE (1) IE66497B1 (fi)
NZ (1) NZ211925A (fi)
PH (1) PH22622A (fi)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU568433B2 (en) * 1984-04-30 1987-12-24 Procter & Gamble Company, The Treating osteoporosis
AU569391B2 (en) * 1984-04-30 1988-01-28 Procter & Gamble Company, The Treating osteoporosis
GR861167B (en) * 1985-05-02 1986-09-30 Research Corp Bone targeted inhibitors of carbonic anhydrase
US4761406A (en) * 1985-06-06 1988-08-02 The Procter & Gamble Company Regimen for treating osteoporosis
CA2035179C (en) * 1990-01-31 2001-08-14 Gerald S. Brenner Pharmaceutical compositions containing insoluble salts of bisphosphonic acids
KR100240358B1 (ko) * 1991-02-26 2000-02-01 제이코버스 코넬리스 레이서 골다공증 치료방법
EP0550385A1 (de) * 1991-12-19 1993-07-07 Ciba-Geigy Ag Peroral zu verabreichende pharmazeutische Zusammensetzungen, die Methandiphosphonsäure-Derivate und 18-Krone-6 Ether enthalten
US5409911A (en) * 1992-09-11 1995-04-25 Merck & Co., Inc. Prostaglandin analog for treating osteoporosis
US20010007863A1 (en) * 1998-06-18 2001-07-12 Merck & Co., Inc. Wet granulation formulation for bisphosphonic acids
CN1157565A (zh) * 1994-09-09 1997-08-20 普罗克特和甘保尔公司 用骨活性膦酸盐和甲状旁腺激素治疗骨质疏松症的方法
FR2727629A1 (fr) * 1994-12-06 1996-06-07 Sanofi Sa Trousse pour cycle de traitement de l'osteoporose
DE69534923T2 (de) * 1994-12-28 2006-11-23 Gador S.A. Anabolische zubereitung für knochenmasse enthaltend olpadronat
HN1996000101A (es) 1996-02-28 1997-06-26 Inc Pfizer Terapia combinada para la osteoporosis
IL120270A0 (en) * 1996-02-28 1997-06-10 Pfizer Combination therapy to treat osteoporosis
AR013994A1 (es) * 1998-10-30 2001-01-31 Gador Sa Procedimiento y preparaciones que modulan selectivamente la funcion del osteoblasto para la prevencion y tratamiento de las osteopatias fragilizantes.
AU1525700A (en) * 1998-11-19 2000-06-05 Board Of Trustees Of The University Of Arkansas, The Increasing bone strength with selected bisphosphonates
US6121253A (en) * 1998-11-20 2000-09-19 Merck Frosst Canada & Co. Prostaglandin conjugates for treating or preventing bone disease
IL145124A0 (en) * 1999-03-05 2002-06-30 Procter & Gamble Methods of increasing bone volume using non-naturally-occuring fp selective agonists and antiresorptive compounds
ATE304856T1 (de) 2000-06-20 2005-10-15 Novartis Pharma Gmbh Methode zur verabreichung von biphosphonaten
JP2004509861A (ja) * 2000-09-13 2004-04-02 ザ、プロクター、エンド、ギャンブル、カンパニー 皮膚及び／又は毛髪を処理するための化粧方法
WO2009131553A2 (en) * 2006-12-29 2009-10-29 Osteogenex Inc. Methods of altering bone growth by administration of sost or wise antagonist or agonist

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3683080A (en) * 1970-08-28 1972-08-08 Procter & Gamble Compositions for inhibiting anomalous deposition and mobilization of calcium phosphate in animal tissue
US4330537A (en) * 1977-12-07 1982-05-18 The Procter & Gamble Company Compositions for inhibiting mobilization of calcium phosphate in animal tissue
US4230700A (en) * 1977-12-07 1980-10-28 The Procter & Gamble Company Methods for inhibiting mobilization of calcium phosphate in animal tissue
AU569391B2 (en) * 1984-04-30 1988-01-28 Procter & Gamble Company, The Treating osteoporosis
AU568433B2 (en) * 1984-04-30 1987-12-24 Procter & Gamble Company, The Treating osteoporosis

Also Published As

Publication number Publication date
IE851084L (en) 1985-10-30
JPH0655675B2 (ja) 1994-07-27
DK193585A (da) 1985-10-31
EP0162510A1 (en) 1985-11-27
AU584611B2 (en) 1989-06-01
DE3583887D1 (de) 1991-10-02
HK46694A (en) 1994-05-20
DK193585D0 (da) 1985-04-30
DE3587956D1 (de) 1995-01-12
AU4176985A (en) 1985-11-07
EP0381296B1 (en) 1994-11-30
EP0162510B1 (en) 1991-08-28
JPS6133117A (ja) 1986-02-17
NZ211925A (en) 1989-01-06
CA1277233C (en) 1990-12-04
EP0381296A1 (en) 1990-08-08
ATE114473T1 (de) 1994-12-15
IE66497B1 (en) 1996-01-10
ATE66608T1 (de) 1991-09-15
PH22622A (en) 1988-10-28
DK173735B1 (da) 2001-08-20
FI851686A0 (fi) 1985-04-29
DE3587956T2 (de) 1995-05-24

Similar Documents

Publication Publication Date Title
FI851686A0 (fi) Redskap foer anvaendning vid behandling av osteoporosis.
DK0663825T3 (da) Anvendelse af melatonin i orale doser til fremkaldelse af søvn
AU598533B2 (en) Synergistic combination of amantadine and selegiline
DE19375061I2 (de) Hexadecylphosphocolin enthaltende arzneimittel mit antitumorwirkung.
MX9405383A (es) Imidazo(4,5-c) piridin-4-aminas.
ES2011120A6 (es) Forma de dosificacion para tratar las enfermedades cardiovasculares.
MX9602442A (es) Un tratamiento con fluoroquinolona a dosis unica elevada.
ATE55695T1 (de) Verwendung von defibrotid zur herstellung pharmazeutischer zusammensetzungen zur behandlung peripherer arteriopathien.
ZA923935B (en) New 2-amino-5-cyano-1,4-dihydropyridines,processes for their preparation and their use in medicaments
NO874241D0 (no) Terapeutisk aktive salter.
IT1224250B (it) Associzione del depiprazolo con la morfina
DE3685177D1 (de) Pharmazeutische zubereitung zur behandlung des bluthochdrucks.
ES2097816T3 (es) Producto y su uso para el tratamiento de estados catabolicos que comprende ifg-1 autentico y cantidades hipocaloricas de nutrientes.
AU551108B2 (en) Analgesic potentiation of zomepirac with butorphanol
DE3879837D1 (de) Pharmazeutische praeparate zur behandlung von zereberalen psycho-organischen syndromen.
DE3650590D1 (de) Verwendung von Tergurid zur Herstellung eines Arzneimittels zur Behandlung geriatrischer Beschwerden
JPS5398730A (en) Input unit
MY102847A (en) Contrast enhancement layer compositions, alkylnitrones, and use.
ZA815094B (en) Novel peptide
JPS528364A (en) Portable device for preventing tooth decay
JPS5349478A (en) Swimming pacemaker
BR8502016A (pt) Semeadeira manual(plantadeira)que pode ser acionada por uma unica mao
UA10995C2 (uk) Препарат "hейтрам" для лікуваhhя hеоhатальhих діарей у телят
SE8604941D0 (sv) Anvendning av ecomer ?72r vid behandling av oral galvanism
AU106297S (en) A patient carrying frame

Legal Events

Date Code Title Description
FC Application refused

Owner name: THE PROCTER & GAMBLE COMPANY